Single-nucleus transcriptomics reveals disease- and pathology-specific signatures in α-synucleinopathies
Brain · 2025
DOI: 10.1093/brain/awae355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2025. Verfasst von Gonzalo S Nido und 9 weiteren Autor:innen. Beteiligte Einrichtung: Neuro-SysMed, Department of Neurology, Haukeland University Hospital, 5021 Bergen, Norway. Hauptthemen laut MEDLINE: Parkinson Disease, Transcriptome, Synucleinopathies. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Research Council of Norway, Bergen Research Foundation, Western Norway Regional Health Authority.
Abstract (Originalsprache)
α-Synucleinopathies are progressive neurodegenerative disorders characterized by intracellular aggregation of α-synuclein, but their molecular pathogenesis remains unknown. Here, we explore cell-specific changes in gene expression across different α-synucleinopathies. We perform single-nucleus RNA sequencing on nearly 300 000 nuclei from the prefrontal cortex of individuals with idiopathic Parkinson’s disease (PD, n = 20), Parkinson’s disease caused by LRRK2 mutations (LRRK2-PD, n = 7), multiple system atrophy (n = 6) and healthy controls (n = 13). Idiopathic PD and LRRK2-PD exhibit a largely overlapping cell type-specific signature, which is distinct from that of multiple system atrophy and includes an overall decrease of the transcriptional output in neurons. Notably, most of the differential expression signal in idiopathic PD and LRRK2-PD is concentrated in a specific deep cortical neuronal subtype expressing adrenoceptor alpha 2A. Although most differentially expressed genes are highly cell type and disease specific, PDE10A is found to be downregulated consistently in most cortical neurons and across all three diseases. Finally, exploiting the variable presence and/or severity of α-synuclein pathology in LRRK2-PD and idiopathic PD, we identify cell type-specific signatures associated with α-synuclein pathology, including a neuronal upregulation of SNCA itself, encoding α-synuclein. Our findings provide new insights into the cell-specific transcriptional landscape of the α-synucleinopathy spectrum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuro-SysMed, Department of Neurology, Haukeland University Hospital, 5021 Bergen, Norway.
- Department of Clinical Medicine, University of Bergen, 5020 Bergen, Norway.
- K.G. Jebsen Center for Translational Research in Parkinson's disease, University of Bergen, 5020 Bergen, Norway.
- The Norwegian Centre for Movement Disorders and Department of Neurology, Stavanger University Hospital, 4068 Stavanger, Norway.
- Department of Mathematics and Natural Sciences, University of Stavanger, 4062 Stavanger, Norway.
ORCID-Profile: Charalampos Tzoulis
Förderung
- Research Council of Norway
- Bergen Research Foundation
- Western Norway Regional Health Authority
Zitieren
APA
Nido, G. S., Castelli, M., Mostafavi, S., Rubiolo, A., Shadad, O., Alves, G., Tysnes, O. B., Flønes, I. H., Dölle, C., & Tzoulis, C. (2025). Single-nucleus transcriptomics reveals disease- and pathology-specific signatures in α-synucleinopathies. Brain. https://doi.org/10.1093/brain/awae355
Vancouver
Nido GS, Castelli M, Mostafavi S, Rubiolo A, Shadad O, Alves G, et al. Single-nucleus transcriptomics reveals disease- and pathology-specific signatures in α-synucleinopathies. Brain. 2025. doi:10.1093/brain/awae355
BibTeX
@article{Nido2025,
author = {Nido, Gonzalo S and Castelli, Martina and Mostafavi, Sepideh and Rubiolo, Anna and Shadad, Omnia and Alves, Guido and Tysnes, Ole-Bjørn and Flønes, Irene H and Dölle, Christian and Tzoulis, Charalampos},
title = {Single-nucleus transcriptomics reveals disease- and pathology-specific signatures in α-synucleinopathies},
journal = {Brain},
year = {2025},
doi = {10.1093/brain/awae355}
}
EUVIMED